[Remote results of using "ECOFLON" prostheses in management of patients with Leriche's syndrome].
The authors analysed the outcomes of 476 reconstructions performed on the aortofemoral segment for Leriche's syndrome using polytetrafluoroethylene grafts "ECOFLON" within the time frame from 1997 to 2007. The in-hospital mortality rate amounted to 2.7%, thrombosis rate to 0.46%, and amputation rate to 0.69%. The remote results were assessed at follow-up terms varying from 6 to 108 months, with the mean follow-up time thus amounting to 34.6 +/- 1.3 months. Secondary graft patency by the first postoperative year amounted to 98.0 +/- 0.62%, by 5 years to 92.5 +/-1.9%, and by 9 years to 91.4 +/- 1.9%, with primary graft patency being 97.3 < or =0.23%, 84.9 +/- 2.9%, and 82.9 +/- 3.5%, respectively. The limb salvage rate amounted to 97 +/-0.6% after 1 year, equalling 91.2< or =2.2% after 5 years, and 80.9 +/- 5.2% after 9 years. Infection of prosthetic grafts occurred in 1.04% of cases (0.42% in the short-, and 1.05 % in the long-term periods). Pseudoaneurysms of distal anastomoses were observed in 0.34% of cases. Analysing two time intervals (i. e., 1997-2002 and 2003-2007) howed a statistically significant betterment of the patency rates (with primary graft patency having increased by 5.3% and secondary graft patency by 5.8%, (P < 0.01), thus apparently suggesting improved quality of explants. It was concluded that polytetrafluoroethylene grafts "ECOFLON" comply with the present-day standards of quality.